Cti biopharma corp. (CTIC)
Income statement / Quarterly
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13Dec'12Sep'12Jun'12Mar'12Dec'11Sep'11Jun'11Mar'11Sep'10Jun'10Sep'09Jun'09
Revenues:
License and contract revenues

0

0

2,289

416

640

14,108

723

613

10,846

-

1,705

22,225

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Product sales, net

-

-

-

-

-

-

-

-

-

-

-

-

626

939

914

1,051

1,223

1,070

745

852

805

2,480

2,021

1,148

1,268

520

362

306

1,126

-

-

-

-

-

-

-

-

-

-

-

-

License and contract revenue

-

-

-

-

-

-

-

-

-

-

-

-

128

8,197

3,519

6,310

35,252

10,254

219

248

1,923

15,309

37,513

195

143

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

License and contract revenue

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

299

20

20

Total revenues

-

-

-

-

-

-

-

-

-

-

-

-

754

9,136

4,433

7,361

36,475

11,324

964

1,100

2,728

17,789

39,534

1,343

1,411

32,884

362

306

1,126

-

-

-

-

-

-

-

-

-

299

20

20

Operating costs and expenses:
Cost of product sold

-

-

-

-

-

-

-

-

-

-

69

78

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Cost of product sold

-

-

-

-

-

-

-

-

-

-

-

-

133

864

163

160

190

736

831

183

190

296

252

202

145

33

13

36

55

-

-

-

-

-

-

-

-

-

-

-

-

Research and development

3,264

4,981

7,598

6,356

5,172

7,928

9,730

9,124

9,685

7,098

7,601

8,914

9,253

9,702

17,716

16,697

20,846

21,432

18,404

19,320

17,471

21,872

16,528

14,017

12,179

10,004

7,245

8,020

8,355

9,121

6,951

8,959

8,170

-

7,530

7,958

-

-

-

-

-

Research and development

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

11,494

5,101

6,914

7,602

7,320

General and administrative

4,467

4,493

4,403

5,053

5,206

5,312

5,763

5,490

5,497

6,983

5,802

7,962

10,688

9,205

15,218

9,571

11,312

15,359

13,682

12,624

12,297

13,136

12,563

13,792

16,750

12,669

8,529

10,102

11,143

9,220

7,763

11,333

9,928

12,993

7,760

8,961

8,576

7,893

13,068

19,667

10,580

Settlement expense

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-95

-

-435

-

-

-

-

-

-

-

-

-1,342

-3,198

Restructuring expenses

0

0

0

0

794

660

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-178

3,820

Acquired in-process research and development

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

29,108

-

-

-

-

-

-

-

-

-

Other operating income

-

-

-

-

-

-

-

-

-

-

0

0

0

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Settlement expense

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

60

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Other operating expenses

4,200

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

253

-

2,719

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Total operating costs and expenses

11,931

9,474

12,001

11,409

11,172

13,900

15,493

14,614

15,182

14,165

13,472

16,954

20,074

14,694

33,097

26,428

32,348

37,527

32,917

32,127

30,211

57,163

32,062

28,011

29,074

22,551

15,847

18,158

19,648

18,850

15,149

49,400

18,098

9,911

15,290

16,919

20,070

12,994

19,982

27,091

21,720

Loss from operations

-11,931

-9,474

-9,712

-10,993

-10,532

208

-14,770

-14,001

-4,336

-13,703

-11,767

5,271

-19,320

-5,558

-28,664

-19,067

4,127

-26,203

-31,953

-31,027

-27,483

-39,374

7,472

-26,668

-27,663

10,333

-15,485

-17,852

-18,522

-18,850

-15,149

-49,400

-18,098

-9,911

-15,290

-16,919

-20,070

-12,994

-19,683

-27,071

-21,700

Non-operating income (expense):
Interest income

119

169

276

347

380

419

436

364

0

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Investment and other income (expense), net

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-270

-99

190

1,574

-14

-78

63

-23

1

26

-

Investment and other income, net

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

37

Interest expense

167

199

240

269

294

316

308

297

288

393

457

488

534

589

634

677

714

-275

1,288

597

494

544

472

467

464

346

316

316

48

5

43

3

5

98

161

222

389

385

776

826

1,583

Amortization of debt discount and issuance costs

130

130

131

130

130

131

130

130

134

50

38

37

38

37

38

38

101

39

40

131

180

181

185

185

178

164

162

164

23

-

-

-

-

110

129

140

167

166

-

-

-

Amortization of debt discount and issuance costs

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

219

227

497

Foreign exchange loss

-77

128

-240

69

-238

665

-46

-1,575

723

42

161

657

-43

-377

-69

-236

198

-142

-18

185

-728

-1,815

-2,455

-160

-5

260

547

5

-751

440

216

-696

384

-502

-1,133

318

759

1,000

-825

183

54

Other non-operating income

-

-

0

0

-

-

0

4,295

-

-

102

-30

-

0

44

-4

-519

93

203

-1,196

0

0

0

1

-886

-

-268

107

-

-

-

-

-

-

-

-

-

-

-

-

-

Gain on derivative liabilities, net

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

1,596

Gain on exchange of convertible notes

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

180

7,201

Other expense

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

272

-

-

-

-

-

-

-

-

-

-

6,000

-

Debt conversion expense

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

2,031

-

-

Total non-operating expense, net

-255

1,288

-335

17

-282

637

-48

2,657

301

-567

-232

102

-615

-1,003

-697

-955

-1,136

187

-1,143

-1,739

-1,402

-2,540

-3,112

-811

-1,533

-363

-199

-368

-1,094

136

-97

-798

569

864

-1,437

-122

266

426

-3,850

-8,006

3,610

Net loss before noncontrolling interest

-

-

-10,047

-10,976

-

845

-14,818

-11,344

-4,035

-14,270

-11,999

5,373

-19,935

-6,561

-29,361

-20,022

2,991

-26,016

-33,096

-32,766

-28,885

-41,914

4,360

-27,479

-29,196

9,970

-15,684

-18,220

-19,616

-18,714

-15,246

-50,198

-17,529

-

-

-

-

-

-

-

-

Net loss before noncontrolling interest

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-16,727

-17,041

-

-

-

-

-

Net loss before noncontrolling interest

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-19,804

-12,568

-23,533

-35,077

-18,090

Noncontrolling interest

-

-

0

-5

-

-1

-9

-8

-14

-4

-25

-25

-107

-189

-178

-256

-321

-379

-504

-170

-288

-345

-243

-80

-194

-226

-140

-209

-232

-113

-57

-60

-83

-80

-65

-44

-70

-46

-51

-53

-63

Net Income (Loss) Attributable to Parent

-

-

-10,047

-10,971

-

846

-14,809

-11,336

-4,021

-14,266

-11,974

5,398

-19,828

-6,372

-29,183

-19,766

3,312

-25,637

-32,592

-32,596

-28,597

-41,569

4,603

-27,399

-29,002

10,196

-15,544

-18,011

-19,384

-18,601

-15,189

-50,138

-17,446

-8,967

-16,662

-16,997

-19,734

-12,522

-23,482

-35,024

-18,027

Preferred Stock Dividends and Other Adjustments

-

-

0

0

-

0

0

0

80

0

0

4,350

0

-

0

0

-

-

-

-

-

-

-

-

-

-

6,900

-

-

-

5,014

-8,458

-

8,901

13,023

5,511

31,283

3,085

30,157

-

-

Preferred stock dividends

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

1

Deemed dividends on preferred stock

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

13,812

9,398

Net loss

-12,186

-8,188

-10,047

-10,971

-10,814

846

-14,809

-11,336

-4,101

-14,266

-11,974

1,048

-19,828

-

-29,183

-19,766

-

-

-

-

-

-

-

-

-

-

-22,444

-

-

-

-20,203

-58,596

-

-17,868

-29,685

-22,508

-51,017

-15,607

-53,639

-48,836

-27,426

Basic (in dollars per share)

-

-

-

-

-

-

-

-

-

-

-

0.03

-

-

-

-0.71

0.12

-

-

-

-0.16

-

0.03

-

-

-

-0.20

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Diluted (in dollars per share)

-

-

-

-

-

-

-

-

-

-

-

0.03

-

-

-

-0.71

0.12

-

-

-

-0.16

-

0.03

-

-

-

-0.20

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Basic (in shares)

-

-

-

-

-

-

-

-

-

-

-

31,725

-

-

-

27,960

27,793

-

-

-

173,936

-

145,138

-

-

-

110,996

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Diluted (in shares)

-

-

-

-

-

-

-

-

-

-

-

31,901

-

-

-

27,960

27,816

-

-

-

173,936

-

147,097

-

-

-

110,996

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Basic and diluted net loss per common share (in dollars per share)

-0.20

-0.14

-0.17

-0.19

-0.19

0.02

-0.26

-0.20

-0.08

-

-0.28

-

-0.71

-

-1.04

-

-

-

-0.19

-0.19

-

-

-

-0.19

-0.20

-

-

-0.17

-0.18

0.21

-0.38

-1.38

-0.43

-2.24

-0.80

-0.14

-0.35

-0.13

-0.48

-0.09

-0.06

Shares used in calculation of basic and diluted net loss per common share (in shares)

62,461

57,976

57,974

57,973

57,973

58,075

57,964

57,941

50,312

-

42,878

-

28,045

-

28,002

-

-

-

176,004

175,458

-

-

-

144,453

142,138

-

-

107

106,697

96,255

52,921

42,532

40,792

-

36,999

165,373

-

-

-

-

-

Shares used in calculation of basic and diluted net loss per common share

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

146,377

118,591

110,993

527,204

446,174